OBJECTIVE: Here we investigated the role of spleen tyrosine kinase (Syk) in the migration induced by platelet-derived growth factor (PDGF) in rat aortic smooth muscle cells (RASMC). METHODS: Cell migration was determined using a Boyden chamber, by wound-healing, and by aortic ring assays. Activity of Syk, mitogen-activated protein kinase (MAPK), and heat shock protein 27 (HSP27) were tested using immunoblotting with kinase inhibitors and small interference RNAs. RESULTS: PDGF-BB induced binding of Syk to the PDGFbeta receptor and increased the phosphorylation of Syk and migration in RASMC. These effects of PDGF-BB were inhibited by piceatannol, an inhibitor of Syk. PDGF-BB increased the phosphorylation of extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK, and HSP27, which were significantly inhibited by piceatannol and in Syk-knockdown cells. The p38 MAPK inhibitor SB203580 and ERK1/2 inhibitor PD98059 inhibited the migration, which was further inhibited by the combination of these inhibitors. SB203580, but not PD98059, inhibited the phosphorylation of HSP27 induced by PDGF-BB in RASMC. PDGF-BB-induced migration was attenuated in HSP27-knockdown cells. Kinase inhibitors and Syk-knockdown diminished PDGF-BB-induced sprout outgrowth in the aortic ring assay. CONCLUSIONS: These results imply that Syk is an upstream signal of the p38 MAPK/HSP27 and ERK1/2 pathways that contributes to PDGF-BB-mediated migration in RASMC.
OBJECTIVE: Here we investigated the role of spleen tyrosine kinase (Syk) in the migration induced by platelet-derived growth factor (PDGF) in rat aortic smooth muscle cells (RASMC). METHODS: Cell migration was determined using a Boyden chamber, by wound-healing, and by aortic ring assays. Activity of Syk, mitogen-activated protein kinase (MAPK), and heat shock protein 27 (HSP27) were tested using immunoblotting with kinase inhibitors and small interference RNAs. RESULTS: PDGF-BB induced binding of Syk to the PDGFbeta receptor and increased the phosphorylation of Syk and migration in RASMC. These effects of PDGF-BB were inhibited by piceatannol, an inhibitor of Syk. PDGF-BB increased the phosphorylation of extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK, and HSP27, which were significantly inhibited by piceatannol and in Syk-knockdown cells. The p38 MAPK inhibitor SB203580 and ERK1/2 inhibitor PD98059 inhibited the migration, which was further inhibited by the combination of these inhibitors. SB203580, but not PD98059, inhibited the phosphorylation of HSP27 induced by PDGF-BB in RASMC. PDGF-BB-induced migration was attenuated in HSP27-knockdown cells. Kinase inhibitors and Syk-knockdown diminished PDGF-BB-induced sprout outgrowth in the aortic ring assay. CONCLUSIONS: These results imply that Syk is an upstream signal of the p38 MAPK/HSP27 and ERK1/2 pathways that contributes to PDGF-BB-mediated migration in RASMC.
Authors: Ekene Onwuka; Cameron Best; Andrew Sawyer; Tai Yi; Eric Heuer; Malik Sams; Matthew Wiet; Hong Zheng; Themis Kyriakides; Christopher Breuer Journal: Regen Med Date: 2017-05-19 Impact factor: 3.806
Authors: Suji Baek; Kang Pa Lee; Long Cui; Yunkyoung Ryu; Jung Min Hong; Junghwan Kim; Seung Hyo Jung; Young Min Bae; Kyung Jong Won; Bokyung Kim Journal: Lasers Med Sci Date: 2017-10-05 Impact factor: 3.161
Authors: Scott R Johnstone; Brett M Kroncke; Adam C Straub; Angela K Best; Clarence A Dunn; Leslie A Mitchell; Yelena Peskova; Robert K Nakamoto; Michael Koval; Cecilia W Lo; Paul D Lampe; Linda Columbus; Brant E Isakson Journal: Circ Res Date: 2012-05-31 Impact factor: 17.367
Authors: L Jiang; X F Wei; D H Yi; P Xu; H Liu; Q Chang; S M Yang; Z F Li; H B Gao; G J Hao Journal: Clin Exp Immunol Date: 2008-11-20 Impact factor: 4.330
Authors: Young Jin Kim; Kang Pa Lee; Do Young Lee; Yun Tae Kim; Suji Baek; Myeong Sik Yoon Journal: Food Sci Biotechnol Date: 2020-03-07 Impact factor: 2.391
Authors: Laura J Sommerville; Chen Xing; Sheri E Kelemen; Satoru Eguchi; Michael V Autieri Journal: Cardiovasc Res Date: 2008-09-08 Impact factor: 10.787